Category: Mergers & AcquisitionsSyndicate content

Boston Scientific, other medtech giants weigh in on mega-mergers

July 29, 2014 by Arezu Sarvestani

A recent spate of mega-mergers hasn't inspired medtech peers to follow suit just yet, according to leadership at Boston Scientific, C.R. Bard and Smith & Nephew.

Boston Scientific, other medtech giants weigh in on mega-mergers

The medical device industry has some blockbuster merger activity in recent months, but a few companies are sitting this one out.

Medtronic pays up to $105 million for Visualase

July 28, 2014 by Brad Perriello

Medtronic says it will pay up to $105 million to acquire Visualase and its MRI-guided neurosurgery laser device.

Medtronic pays up to $105 million for Visualase

Medtronic (NYSE:MDT) said today that it paid up to $105 million to acquire Visualase and its MRI-guided laser neurosurgery device.

Elekta eyes Turkish radiology market with acquisition of Mesi Medikal

July 24, 2014 by Arezu Sarvestani

Elekta hopes to meet Turkey's radiotherapy "shortage" through its acquisition of local distributor Mesi Medikal.

Elekta eyes Turkish radiology market with acquisition of Mesi Medikal

Report: Medtronic shareholder sues to block Covidien merger

July 24, 2014 by Brad Perriello

A Medtronic shareholder is reportedly looking to block the pending, $43 billion merger with Covidien, arguing that the deal leaves stockowners on the hook for significant tax liabilities.

Report: Medtronic shareholder sues to block Covidien merger

Ulthera pulls $86M IPO in favor of $600M merger

July 23, 2014 by Arezu Sarvestani

Aesthetics devices maker Ulthera withdraws its $86 million initial public offering after agreeing to an acquisition by Merz that's valued at up to $600 million.

Ulthera pulls IPO in favor of merger

Arizona device maker Ulthera is ditching its planned initial public offering in favor of a $600 million merger with larger aesthetics company Merz Inc., according to an SEC filing.

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta

Allergan cuts 1,500 jobs, faces SEC complaint

July 21, 2014 by Arezu Sarvestani

Botox-maker Allergan announces restructuring measures that will cut 13% of its global workforce as the company sinks deeper into a months-long battle against activist investors and attempts at a takeover.

Updated July 21, 2014, at 12:40 p.m. EST with additional information on Allergan's earnings.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp